Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles - Tabular View

Tracking Information

First Received Date ^ICMJE

April 8, 2008

Last Updated Date

April 11, 2008

Start Date ^ICMJE

January 2008

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

Original Primary Outcome Measures ^ICMJE

Change History

Complete list of historical versions of study NCT00658294 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles

Official Title ^ICMJE

Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles in Patients With Inoperable Alveolar Echinococcosis Using PET-CT and EmII/3-10 Serology

Brief Summary

The aim of this study is to evaluate PET-CT and EmII/3-10 serology as potential markers to assess the parasitocidal effect of benzimidazoles

Trial with medicinal product

Detailed Description

Study Phase

Phase IV

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Cohort, Prospective

Condition ^ICMJE

Alveolar Echinococcosis

Intervention ^ICMJE

Other: Stop treatment

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Estimated Enrollment ^ICMJE

Estimated Completion Date

January 2009

Primary Completion Date

Eligibility Criteria ^ICMJE

Inclusion criteria:

Patients with inoperable alveolar echinococcosis
With negative PET-CT
EmII/3-10 serology under long-term chemotherapy with benzimidazoles

Exclusion criteria:

Positive PET-CT
Positive EmII-3-10 Serology
No compliance
Reduced life expectancy
Pregnancy

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact: 01 Studienregister MasterAdmins

41-044-255-1111

Location Countries ^ICMJE

Switzerland

Administrative Information

NCT ID ^ICMJE

NCT00658294

Responsible Party

Beat Müllhaupt, University Hospital Zurich

Study ID Numbers ^ICMJE

EK-1351

Study Sponsor ^ICMJE

University of Zurich

Collaborators ^ICMJE

Investigators ^ICMJE

Principal Investigator:

Beat Müllhaupt 01 Studienregister MasterAdmins

UniversitaetsSpital Zuerich

Information Provided By

University of Zurich

Verification Date

April 2008

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP